Efficacy of second-line chemotherapy after a first-line triplet in patients with metastatic colorectal cancer

BACKGROUND: Exposing patients with metastatic colorectal cancer (mcrc) to all three active chemotherapeutic agents (oxaliplatin, irinotecan, fluorouracil) has improved survival. The benefit of second-line chemotherapy after a first-line triplet is not clearly defined. We evaluated the efficacy of se...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Curr Oncol
Autors principals: Bazarbashi, S., Hakoun, A.M., Gad, A.M., Elshenawy, M.A., Aljubran, A., Alzahrani, A.M., Eldali, A.
Format: Artigo
Idioma:Inglês
Publicat: Multimed Inc. 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6380651/
https://ncbi.nlm.nih.gov/pubmed/30853806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.26.4217
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars